(Q35083831)

6 August 2017

Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer (English)

1 reference

6 August 2017

0 references

1 reference

4

Juan P Wisnivesky

1 reference

6 August 2017

Sirisha Jonnalagadda

1

1 reference

6 August 2017

Jacqueline Arcinega

series ordinal

2

1 reference

6 August 2017

Cardinale Smith

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

30 March 2011

1 reference

6 August 2017

1 reference

6 August 2017

117

1 reference

6 August 2017

20

1 reference

6 August 2017

4724-4731

1 reference

Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128666

Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128666

Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128666

Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128666

Ratios of involved nodes in early breast cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128666

Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128666

Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128666

Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128666

Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128666

Significance of the number of positive lymph nodes in resected non-small cell lung cancer.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128666

Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128666

Significance of the Number of Positive Lymph Nodes in Resected Non-small Cell Lung Cancer

27 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.26093

Prognostic significance of the number of lymph node metastases in esophageal cancer

21 January 2018

1 reference

12 December 2020

A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer

1 reference

12 December 2020

Limited resection for the treatment of patients with stage IA lung cancer

1 reference

12 December 2020

Prognostic significance of surgical-pathologic multiple-station N1 disease in non-small cell carcinoma of the lung

1 reference

12 December 2020

Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer

1 reference

12 December 2020

Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases

1 reference

12 December 2020

Assessing the prognostic value of the extent of mediastinal lymph node infiltration in surgically-treated non-small cell lung cancer (NSCLC)

1 reference

12 December 2020

Superiority of ratio based lymph node staging for bladder cancer

1 reference

12 December 2020

Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis

1 reference

12 December 2020

Independent predictive value of the overall number of metastatic N1 and N2 stations in lung cancer

1 reference

12 December 2020

Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer

1 reference

12 December 2020

Accuracy of cancer death certificates and its effect on cancer mortality statistics

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.26093

1 reference

6 August 2017

1 reference

6 August 2017

1 reference